(Q46768564)

English

Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate

scientific article published on 19 October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

meglumine antimoniate

1 reference

based on heuristic

inferred from title

author name string

Ioannis Vouldoukis

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

Sandrine Rougier

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

Bernard Dugas

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

Paco Pino

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

Dominique Mazier

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

Frédérique Woehrlé

6

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

publication date

19 October 2005

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

Veterinary Parasitology

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

135

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

137-146

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Topoisomerases in kinetoplastids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

The topoisomerases of protozoan parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Limited activity of bacterial DNA topoisomerase II inhibitors against Leishmania donovani and Trypanosoma cruzi amastigotes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Functional discrimination between interleukin 6 and interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Interleukin 6 is involved in interleukin 1-induced activities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Human visceral leishmaniasis in Alpes-Maritimes, France: epidemiological characteristics for the period 1985-1992.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Seven years survey of susceptibility to marbofloxacin of bovine pathogenic strains from eight European countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Interferon-gamma, the activated macrophage, and host defense against microbial challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Cytokines that regulate macrophage production of nitrogen oxides and expression of antileishmanial activities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis. Veterinary Group of Lupino

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Inflammation, immunoregulation, and inducible nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Immunization of dogs with a Leishmania infantum-derived vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Novobiocin antagonism of amastigotes of Trypanosoma cruzi growing in cell-free medium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Infection of a canine macrophage cell line with leishmania infantum: determination of nitric oxide production and anti-leishmanial activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Potent antibacterial fluoroquinolones with marked activity against Leishmania donovani in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Sodium stibogluconate (Pentostam) potentiates oxidant production in murine visceral leishmaniasis and in human blood

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Dual inhibition of DNA topoisomerases of Leishmania donovani by novel indolyl quinolines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Inhibitors of trypanosome topoisomerases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Emergence of zoonotic canine leishmaniasis in the United States: isolation and immunohistochemical detection of Leishmania infantum from foxhounds from Virginia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Infections in immunocompetent and immune-deficient mice with promastigotes of a North American isolate of Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Flow cytometric analysis of cellular immune responses in dogs experimentally infected with a North American isolate of Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Inducible nitric oxide synthase expression in Leishmania-infected dog macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Canine leishmaniasis. A review based on 95 cases in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

DNA topoisomerases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Microscopic observation of progressive immobilization of leishmania promastigotes in acridine orange stain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficient immunity against Leishmania major in the absence of interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VETPAR.2005.09.003

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46768564&oldid=2130887509"